v3.26.3
Subsequent Events - Additional Information (Details) - Subsequent Event
$ in Millions
Oct. 21, 2026
USD ($)
ft²
Oct. 08, 2026
USD ($)
Product
Oct. 02, 2026
USD ($)
ft²
a
License Agreement      
Subsequent Event [Line Items]      
Non-refundable upfront license fee   $ 10.0  
Maximum development and regulatory milestone payment   165.0  
Maximum license fee and milestone payment   175.0  
Potential milestone payment   $ 875.0  
License Agreement | Minimum      
Subsequent Event [Line Items]      
Percentage of tiered royalties on annual net sales of licensed products   3.00%  
License Agreement | Maximum      
Subsequent Event [Line Items]      
Percentage of tiered royalties on annual net sales of licensed products   8.00%  
Huntsville Facility | Development Agreement and Related Lease Agreement      
Subsequent Event [Line Items]      
Area of square feet | ft²     259,000
Area of land | a     25
Project estimated cost     $ 42.0
RevOpsis Therapeutics, Inc. | License Agreement      
Subsequent Event [Line Items]      
Number of additional retinal products | Product   4  
Aliso Facility      
Subsequent Event [Line Items]      
Area of square feet | ft² 40,000    
Allocated purchase price $ 15.2